Table 7. Immunophenotyping results for CLL patients
Patient number |
Ly 109/L |
CD 19 % |
CD 5 |
CD 23 |
CD 43 |
Fmc7 |
CD 79b |
CD 20 |
sIg |
К % |
λ% |
К/λ |
MS |
CD 38
|
13 |
69.4 |
+ 80 |
+ |
+ |
+ |
- |
+ |
± |
+ |
100 |
0 |
|
5 |
- |
14 |
30.0 |
+ 69 |
+ |
+ |
+ |
- |
+ |
+ |
+ |
2 |
98 |
0.02 |
5 |
- |
15 |
276.5 |
+ 88 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
5 |
95 |
0.05 |
4 |
+ |
16 |
910.5 |
+ 96 |
+ |
+ |
+ |
- |
+ |
+ |
+ |
2 |
98 |
0.02 |
5 |
+ |
17 |
21.9 |
+ 83 |
+ |
+ |
+ |
- |
± |
± |
± |
2 |
98 |
0.02 |
5 |
+ |
18 |
33.7 |
+ 90 |
+ |
+ |
+ |
- |
+ |
+ |
+ |
100 |
0 |
0 |
5 |
+ |
19 |
258.5 |
+ 93 |
+ |
+ |
+ |
- |
+ |
+ |
+ |
4 |
96 |
0.04 |
5 |
- |
20 |
188.5 |
+ 97 |
+ |
+ |
+ |
- |
+ |
+ |
+ |
0 |
100 |
|
5 |
+ |
Abbreviations: Ly, lymphocytes; MS, Matutes score ; sIg, surface immunoglobulin.